Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
15-hydroxyprostaglandin dehydrogenase | 0.516 | 0.731 | 1.4E-05 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2003 | 2004 | ||||||||
|
2'-5'-oligoadenylate synthetase 2 | 0.670 | 0.538 | 2.6E-21 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
2'-5'-oligoadenylate synthetase 3 | 0.608 | 0.615 | 2.0E-33 |
|
phenotype | 0.010 | None | 1.000 | 1 | 2 | 2010 | 2010 | ||||||||
|
2,4-dienoyl-CoA reductase 1 | 0.426 | 0.885 | 4.5E-14 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 1980 | 2018 | ||||||||
|
5-hydroxytryptamine receptor 1A | 0.522 | 0.846 | 0.20 |
|
phenotype | 0.410 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2010 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 5A | 0.716 | 0.231 | 6.3E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
8-oxoguanine DNA glycosylase | 0.453 | 0.808 | 3.9E-12 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2017 | ||||||||
|
Abelson helper integration site 1 | 0.513 | 0.846 | 1.1E-25 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
acetylcholinesterase (Cartwright blood group) | 0.445 | 0.885 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 1990 | 2017 | ||||||||
|
activating transcription factor 6 | 0.516 | 0.846 | 3.2E-07 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | ||||||||
|
activating transcription factor 7 interacting protein | 0.543 | 0.769 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
activation induced cytidine deaminase | 0.463 | 0.885 | 9.2E-06 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
activator of HSP90 ATPase activity 1 | 0.396 | 0.923 | 1.00 |
|
phenotype | 0.060 | None | 1.000 | 6 | 0 | 2004 | 2019 | ||||||||
|
activator of HSP90 ATPase homolog 2, pseudogene | 0.805 | 0.346 | 1.8E-04 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
acyl-CoA binding domain containing 3 | 0.805 | 0.385 | 1.1E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
ADAM metallopeptidase domain 17 | 0.453 | 0.808 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 13 | 0.496 | 0.769 | 5.1E-15 |
|
phenotype | 0.120 | None | 1.000 | 2 | 1 | 2004 | 2014 | ||||||||
|
adenosine deaminase RNA specific | 0.501 | 0.808 | 2.6E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
adenylate cyclase activating polypeptide 1 | 0.510 | 0.846 | 0.52 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
adhesion G protein-coupled receptor V1 | 0.572 | 0.731 | 3.2E-39 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2004 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
age-related maculopathy susceptibility 2 | 0.670 | 0.308 | 5.2E-04 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2004 | 2015 |